Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX)

CUSIP: 03237H101

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
110,465,093
Total 13F shares
48,572,530
Share change
+11,080,479
Total reported value
$1,794,757,212
Put/Call ratio
48%
Price per share
$36.95
Number of holders
131
Value change
+$422,522,242
Number of buys
91
Number of sells
35

Security key

03237H101

Report period

Q4 2022

Institutions

131

Top holders

10

Top shareholders of AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VIKING GLOBAL INVESTORS LP
13F 3/4/5
Company · 10%+ Owner
5.2%
5,770,536
$162,441,000 30 Sep 2022
PERCEPTIVE ADVISORS LLC
13F
Company
5%
5,472,033
$154,038,000 30 Sep 2022
13F
VANGUARD GROUP INC
13F
Company
3.2%
3,514,356
$98,929,000 30 Sep 2022
13F
BlackRock Finance, Inc.
13F
Company
2.1%
2,295,834
$64,628,000 30 Sep 2022
13F
Boxer Capital, LLC
13F
Company
1.9%
2,084,000
$58,665,000 30 Sep 2022
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
1.2%
1,350,000
$38,003,000 30 Sep 2022
13F
FEDERATED HERMES, INC.
13F
Company
1.2%
1,329,000
$37,411,000 30 Sep 2022
13F
Bain Capital Life Sciences Investors, LLC
13F
Company
0.93%
1,023,214
$28,803,000 30 Sep 2022
13F
Woodline Partners LP
13F
Company
0.92%
1,020,384
$28,724,000 30 Sep 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.83%
921,128
$25,930,000 30 Sep 2022
13F
STATE STREET CORP
13F
Company
0.75%
827,068
$23,282,000 30 Sep 2022
13F
CITADEL ADVISORS LLC
13F
Company
0.73%
806,830
$22,712,000 30 Sep 2022
13F
Alpha Wave Global, LP
13F
Company
0.63%
700,635
$19,723,000 30 Sep 2022
13F
Avoro Capital Advisors LLC
13F
Company
0.59%
650,000
$18,298,000 30 Sep 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.58%
635,556
$17,890,000 30 Sep 2022
13F
Cormorant Asset Management, LP
13F
Company
0.55%
610,000
$17,172,000 30 Sep 2022
13F
EMERALD ADVISERS, LLC
13F
Company
0.54%
601,226
$16,925,000 30 Sep 2022
13F
Ghost Tree Capital, LLC
13F
Company
0.5%
550,000
$15,483,000 30 Sep 2022
13F
EMERALD MUTUAL FUND ADVISERS TRUST
13F
Company
0.43%
471,887
$13,284,000 30 Sep 2022
13F
Point72 Asset Management, L.P.
13F
Company
0.42%
466,961
$13,145,000 30 Sep 2022
13F
Soleus Capital Management, L.P.
13F
Company
0.39%
429,336
$12,086,000 30 Sep 2022
13F
Rock Springs Capital Management LP
13F
Company
0.37%
403,737
$11,365,000 30 Sep 2022
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.35%
382,212
$10,759,000 30 Sep 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.34%
379,399
$10,680,000 30 Sep 2022
13F
Nuveen Asset Management, LLC
13F
Company
0.32%
356,687
$6,385,000 30 Sep 2022
13F
MARSHALL WACE, LLP
13F
Company
0.31%
341,064
$9,600,000 30 Sep 2022
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.29%
325,700
$9,168,000 30 Sep 2022
13F
Verition Fund Management LLC
13F
Company
0.28%
312,416
$8,795,000 30 Sep 2022
13F
NORTHERN TRUST CORP
13F
Company
0.26%
285,808
$8,045,000 30 Sep 2022
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.24%
269,498
$7,586,000 30 Sep 2022
13F
MORGAN STANLEY
13F
Company
0.24%
269,068
$7,575,000 30 Sep 2022
13F
Invesco Ltd.
13F
Company
0.24%
261,536
$7,362,000 30 Sep 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.22%
240,739
$6,777,000 30 Sep 2022
13F
SECTORAL ASSET MANAGEMENT INC
13F
Company
0.19%
205,400
$5,782,000 30 Sep 2022
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.17%
191,334
$5,386,000 30 Sep 2022
13F
D. E. Shaw & Co., Inc.
13F
Company
0.15%
162,265
$4,568,000 30 Sep 2022
13F
Bank of New York Mellon Corp
13F
Company
0.11%
116,939
$3,292,000 30 Sep 2022
13F
SIMPLEX TRADING, LLC
13F
Company
0.11%
116,604
$3,282,000 30 Sep 2022
13F
GROUP ONE TRADING LLC
13F
Company
0.08%
88,985
$2,505,000 30 Sep 2022
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.06%
68,652
$1,933,000 30 Sep 2022
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.06%
67,875
$1,911,000 30 Sep 2022
13F
SEI INVESTMENTS CO
13F
Company
0.06%
63,674
$1,792,000 30 Sep 2022
13F
ExodusPoint Capital Management, LP
13F
Company
0.06%
62,219
$1,751,000 30 Sep 2022
13F
Walleye Capital LLC
13F
Company
0.06%
61,882
$1,742,000 30 Sep 2022
13F
RHUMBLINE ADVISERS
13F
Company
0.04%
45,793
$1,289,000 30 Sep 2022
13F
Belvedere Trading LLC
13F
Company
0.04%
43,499
$1,627,000 30 Sep 2022
13F
BROWN ADVISORY INC
13F
Company
0.04%
43,441
$1,223,000 30 Sep 2022
13F
Caption Management, LLC
13F
Company
0.04%
42,947
$1,209,000 30 Sep 2022
13F
Kestra Advisory Services, LLC
13F
Company
0.04%
42,683
$1,202,000 30 Sep 2022
13F
Squarepoint Ops LLC
13F
Company
0.04%
41,792
$1,176,000 30 Sep 2022
13F

Institutional Holders of Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX) as of Q4 2022

As of 31 Dec 2022, Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX) was held by 131 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 48,572,530 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC, BlackRock Inc., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Point72 Asset Management, L.P., Boxer Capital, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., FEDERATED HERMES, INC., and D. E. Shaw & Co., Inc.. This page lists 131 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
90
Q4 2022 holders
131
Holder diff
41
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 Value $ Q4 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .